CatalystPit
TerminalPit ConsensusInsidersPoliticiansInstitutionsNewsScreener

EIKNEikon Therapeutics, Inc.

NASDAQ · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Last close $8.04 · 2026-09-30
ABOUT
ExchangeNASDAQ
SectorHealthcare
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Market cap$435.49M
CountryUSA
RECENT INSIDER TRADES
  • 2026-09-08 · Column Group IV GP, LP (10% Owner) · BUY
  • 2026-02-09 · Column Group IV GP, LP (10% Owner) · BUY
  • 2026-02-06 · Lux Venture Partners V, LLC (10% Owner) · BUY
INSTITUTIONAL OWNERSHIP
Institutional holders77
Shares held26,490,842
Value$310.22M
Percent of shares outstanding48.91%
As of quarter end2026-06-30
RECENT NEWS
  • Eikon Therapeutics presents at Morgan Stanley 24th Annual Global Healthcare Conference
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS
Eikon Therapeutics, Inc. (EIKN) · Stock Price, Insider Trades, Institutional Holdings · CatalystPit